Skip to main content
OpenTrials
Completed

NCT Number: NCT05391269

Review of the Pathological Results of Appendectomy Specimens

This is a retrospective review study to evaluate the histopathological findings post appendectomy

Completed

Looking for future studies?

Notify Me

Key information

About this study

In this study, 940 cases will be reviewed. Patient demographics, accuracy of imaging modalities, and histopathological findings will be described.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients underwent an appendectomy in king Abdulaziz university hospital in the period between 2010-2017

Exclusion criteria

  • Any other patients will be excluded from the study

Treatment and study plan

Primary outcomes

  1. Description of histopathological findings post appendectomy

    Time frame: 2010-2017

    Description of histopathological findings post appendectomy

Secondary outcomes

  1. Relation between disease age, and gender

    Time frame: 2010-2017

    Relation between disease age, and gender

  2. Assessment for accuracy of imagining modalities

    Time frame: 2010-2017

    Assessment for accuracy of imagining modalities

Sponsors and collaborators

Lead sponsor

King Abdulaziz University

Other

Registry information

Official study title

Histopathological Examination of Cases With Acute Appendicitis, A Retrospective Study at King Abdulaziz University Hospital, Jeddah, Saudi Arabia

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
May 25, 2022
Registry last updated
Jun 3, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.